Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“MAPS' MDMA/PTSD research for the European Medicines Agency (EMA) is also moving forward, starting to take place this summer or early fall in the Czech Republic, the Netherlands, and the United Kingdom, with Germany, Portugal, Finland, and Norway to follow.”
· From the Desk of Rick Doblin, Ph.D. – Summer 2020 · own post

Summer 2020 column. Start timing and country sequence for European Phase 2 therapist-training studies toward an EMA submission.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.